✦ LIBER ✦

305 In vitro evaluation of a doxorubicin-antibody conjugate, on non-Hodgkin's lymphoma and multiple myeloma cell lines

✍ Scribed by P. Sapra; G. Griffiths; M. Hayes; R. Stein; J. Pickett; S. Govindan; A. Sheerin; H. Hansen; I. Horak; D. Goldenberg

Book ID: 118621488
Publisher: Elsevier Science
Year: 2004
Tongue: English
Weight: 141 KB
Volume: 2
Category: Article
ISSN: 1359-6349
DOI: 10.1016/s1359-6349(04)80313-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Mobilization of peripheral blood stem ce

Mobilization of peripheral blood stem cells for autologous transplant in non-Hodgkin's lymphoma and multiple myeloma patients by plerixafor and G-CSF and detection of tumor cell mobilization by PCR in multiple myeloma patients

✍ Fruehauf, S; Ehninger, G; Hübel, K; Topaly, J; Goldschmidt, H; Ho, A D; Müller, 📂 Article 📅 2009 🏛 Nature Publishing Group 🌐 English ⚖ 136 KB

Effect of Cytochrome P450 3A4 Inducers o

Effect of Cytochrome P450 3A4 Inducers on the Pharmacokinetic, Pharmacodynamic and Safety Profiles of Bortezomib in Patients with Multiple Myeloma or Non-Hodgkin’s Lymphoma

✍ Professor Andrzej Hellmann, Simon Rule, Jan Walewski, Ofer Shpilberg, Huaibao Fe 📂 Article 📅 2011 🏛 Springer International Publishing AG 🌐 English ⚖ 207 KB

Feasibility and toxicity of high-dose th

Feasibility and toxicity of high-dose therapy (HDT) supported by peripheral blood stem cells in elderly patients with multiple myeloma and non-Hodgkin's lymphoma: Survey from a single institution

✍ Massimo Magagnoli; Luca Castagna; Monica Balzarotti; Barbara Sarina; Inna Timofe 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 71 KB 👁 2 views

Peripheral blood mobilization of differe

Peripheral blood mobilization of different lymphocyte and dendritic cell subsets with the use of intermediate doses of G-CSF in patients with non-Hodgkin’s lymphoma and multiple myeloma

✍ J. Vela-Ojeda; M. A. García-Ruiz Esparza; E. Reyes-Maldonado; L. Jiménez-Zamudio 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 120 KB

Treatment with Plerixafor in non-Hodgkin

Treatment with Plerixafor in non-Hodgkin's Lymphoma and Multiple Myeloma Patients to Increase the Number of Peripheral Blood Stem Cells When Given a Mobilizing Regimen of G-CSF: Implications for the Heavily Pretreated Patient

✍ Patrick Stiff; Ivana Micallef; Philip McCarthy; Margarida Magalhaes-Silverman; D 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 273 KB

Safety and preliminary efficacy of pleri

Safety and preliminary efficacy of plerixafor (Mozobil) in combination with chemotherapy and G-CSF: an open-label, multicenter, exploratory trial in patients with multiple myeloma and non-Hodgkin's lymphoma undergoing stem cell mobilization

✍ Dugan, M J; Maziarz, R T; Bensinger, W I; Nademanee, A; Liesveld, J; Badel, K; D 📂 Article 📅 2009 🏛 Nature Publishing Group 🌐 English ⚖ 237 KB